With obesity rates surging, GLP-1 receptor agonists (GLP-1 RAs) are showing promise as effective weight-loss treatments, with significant results for…
Browsing: Clinical Updates
Dr. Kyle Staller, a gastroenterologist and neurogastroenterologist at Mass General, unpacks the complexities of IBS-C diagnosis, addressing common misconceptions and…
Interim results from the phase 3 ESSENCE trial reveal that semaglutide, a GLP-1 receptor agonist, is effective in treating metabolic…
Lowering the positivity threshold of a commercial fecal immunochemical test (FIT) can enhance its sensitivity to levels comparable to next-generation…
At DDW 2024, Dr. Rajesh N. Keswani, director of endoscopy at Northwestern Memorial Hospital, addressed common misconceptions and nonadherence to…
Lucid Diagnostics has submitted its complete clinical evidence package to Medicare’s Molecular Diagnostics Program (MolDX), seeking reconsideration of a Local…
The American Gastroenterological Association (AGA) has released updated guidelines for managing moderate-to-severe ulcerative colitis (UC), emphasizing advanced pharmacological therapies and…
Multi-cancer early detection (MCED) tests represent a transformative breakthrough in cancer diagnostics, using blood samples to identify biomarkers like circulating…
Dr. David Johnson shared key highlights from the 2024 American College of Gastroenterology (ACG) Annual Scientific Meeting, including promising research…
The American Gastroenterological Association (AGA) recently reviewed endoscopic scoring systems used to evaluate the severity of inflammation and mucosal healing…